← Back to Analyst Consensus 
ARWR Buy
ARROWHEAD PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 23, 2026 (28 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Oct 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 8, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Sep 1, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 31, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Aug 31, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 30, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 23, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 23, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Jul 22, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jul 17, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 14, 2026 | Stifel | initiate | — → Buy | — | 53% |
| Jul 1, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 30, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jun 17, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | — | 50% |
| May 13, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| May 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 1, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
| Apr 21, 2026 | Morgan Stanley | upgrade | Equal-Weight → Overweight | — | 54% |
| Mar 25, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Jan 22, 2026 | B. Riley Securities | maintain | Buy → Buy | $101 | 54% |
| Jan 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $100 | 44% |
| Jan 13, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $110 | 54% |
| Jan 7, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $85 | 54% |
| Jan 7, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $81 | 54% |
| Jan 7, 2026 | Chardan Capital | maintain | Buy → Buy | $80 | 47% |
| Dec 17, 2025 | Piper Sandler | maintain | Overweight → Overweight | $100 | 54% |
| Dec 11, 2025 | RBC Capital | maintain | Outperform → Outperform | $80 | 55% |
| Dec 9, 2025 | B of A Securities | maintain | Buy → Buy | $81 | 53% |
| Dec 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $85 | 44% |
| Dec 1, 2025 | B of A Securities | maintain | Buy → Buy | $62 | 53% |
| Dec 1, 2025 | Chardan Capital | maintain | Buy → Buy | $60 | 47% |
| Nov 26, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $48 | 54% |
| Nov 20, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $48 | 54% |
| Nov 19, 2025 | RBC Capital | maintain | Outperform → Outperform | $52 | 55% |
| Nov 19, 2025 | Chardan Capital | maintain | Buy → Buy | $60 | 47% |
| Nov 19, 2025 | Piper Sandler | maintain | Overweight → Overweight | $70 | 54% |
| Nov 12, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $45 | 54% |
| Oct 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Sep 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Aug 11, 2025 | Chardan Capital | maintain | Buy → Buy | $60 | 47% |
| Aug 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $38 | 55% |
| May 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| May 13, 2025 | Citigroup | maintain | Neutral → Neutral | $17 | 54% |
| May 13, 2025 | Chardan Capital | maintain | Buy → Buy | $60 | 47% |
| Feb 14, 2025 | B. Riley Securities | reiterate | Buy → Buy | $38 | 54% |
| Feb 12, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
Price Target Trend
May 12, 2026 Latest: $107.71 Oct 23, 2026
EPS Estimates
+1q $-1.37
Lo: $-1.75 Hi: $-1.00
7 analysts 0y $-3.51
Lo: $-5.14 Hi: $-2.45
15 analysts +1y $-4.98
Lo: $-6.58 Hi: $-2.66
15 analysts ▲1
0q $-1.50
Lo: $-3.00 Hi: $-0.35
15 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days